Cargando…

Immune-Mediated Necrotizing Myopathy Initially Presenting as Erythema Nodosum

Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune myopathy characterized by severe diffuse proximal myofiber necrosis in the context of inflammatory myopathy. Autoantibodies of anti-signal recognition particle and anti-hydroxy-3-methylglutaryl-CoA reductase are two antibodies speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Shuni, Li, Sheng, Tang, Shunli, Sun, Qingmiao, Fang, Deren, Li, Yali, Zhu, Dingxian, Fang, Hong, Qiao, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457844/
https://www.ncbi.nlm.nih.gov/pubmed/32922062
http://dx.doi.org/10.2147/JIR.S270114
Descripción
Sumario:Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune myopathy characterized by severe diffuse proximal myofiber necrosis in the context of inflammatory myopathy. Autoantibodies of anti-signal recognition particle and anti-hydroxy-3-methylglutaryl-CoA reductase are two antibodies specific to IMNM. Erythema nodosum (EN) is often accompanied by various systemic diseases, such as autoimmune diseases. Herein, we report a female patient with signal recognition particle-associated IMNM, with EN as the first presentation. She showed significant clinical improvement after the initiation of glucocorticoids, intravenous immunoglobulin, rituximab, and mycophenolate mofetil. This case indicates that IMNM can initially present as EN. IMNM and EN might have overlapping pathogeneses.